paroxetine has been researched along with Anxiety in 117 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (11.97) | 18.2507 |
| 2000's | 49 (41.88) | 29.6817 |
| 2010's | 46 (39.32) | 24.3611 |
| 2020's | 8 (6.84) | 2.80 |
| Authors | Studies |
|---|---|
| Bannerman, DM; Collins, HM; Ozdemir, D; Pinacho, R; Sharp, T | 1 |
| Arasu, R; Badeshae, S; Chen, W; Furlong, Y | 1 |
| Cao, J; Chen, D; Chen, JX; Chen, X; Guo, CL; Han, XY; Hong, X; Jiao, XZ; Jiao, YX; Li, MX; Liang, S; Liu, HM; Meng, S; Qi, JX; Wang, TT; Zhao, Y | 1 |
| Cattaneo, CI; De Berardis, D; Fornaro, M; Martinotti, G; Ressico, FV; Vieta, E | 1 |
| Garabadu, D; Krishnamurthy, S; Prajapati, SK; Singh, N | 1 |
| Liao, XM; Si, TM; Su, YA; Wang, Y; Yu, X | 1 |
| Albrechtsen, A; Buller, R; Eriksson, H; Hobart, M; Lindgreen, S; Moltke, I; Nøhr, AK | 1 |
| Aksoy, S; Atıcı, M; Erdogan, MS; Ertaş, ET; Isa Kara, M; Kelebek, S; Ozen, E | 1 |
| Campbell Burton, CA; Chun, HY; Gillespie, D; Holmes, J; Knapp, P; Lewis, SR; Lightbody, CE; Murray, J; Watkins, CL | 1 |
| Emilsson, JF; Eriksson, E; Hieronymus, F; Lisinski, A; Näslund, J; Nilsson, S | 1 |
| Jiang, H; Liu, D; Liu, Y; Pan, F; Xu, J | 1 |
| Agius, M; Ripullone, K; Womersley, K | 1 |
| Coimbra, JPC; Coimbra, NC; de Freitas, RL; Dos Anjos-Garcia, T; Falconi-Sobrinho, LL; Laure, CJ; Paschoalin-Maurin, T | 1 |
| He, JC; Pu, ZP; Xia, JM; Xie, W | 1 |
| Burke, AK; Chaudhury, SR; Ellis, SP; Grunebaum, MF; Keilp, JG; Mann, JJ; Marver, JE; Metts, AV; Oquendo, MA; Parris, MS | 1 |
| Li, P; Ma, C | 1 |
| Bahto, A; Delić, D; Džubur Kulenović, A; Hadžimuratović, A; Halilović, Z; Kapo, B; Mašnić, H; Memić Serdarević, A | 1 |
| Cai, H; Gong, X; Guo, Y; Han, W; Jiang, P; Liao, D; Liu, M | 1 |
| Bleau, P; Hedeker, H; Moskowitz, DS; Pinard, G; Rappaport, LM; Russell, JJ | 1 |
| Bassi, M; Cauli, G; Gala, C; Iapichino, E; Marconi, AM; Quartieri Bollani, M; Rucci, P | 1 |
| Franc, B; Lanfumey, L; Martin, V; Mongeau, R; Poilbout, C; Règue, M | 1 |
| Blake, CS; Hudd, TR; Nguyen, TT; Rimola-Dejesus, Y; Zaiken, K | 1 |
| Juřica, J; Žourková, A | 1 |
| Bernstein, GA; Book, SW; Kushner, MG; Miller, PM; Randall, CL; Randall, PK; Smith, JP; Specker, SM; Thomas, SE | 1 |
| Asarnow, JR; Birmaher, B; Brent, DA; Clarke, GN; Emslie, GJ; He, J; Hilton, RC; Keller, MB; Mansoor, B; Mayes, T; Porta, G; Rengasamy, M; Ryan, N; Shamseddeen, W; Wagner, KD | 1 |
| Amsterdam, JD; DeRubeis, RJ; Fournier, JC; Gallop, R; Hollon, SD; Shelton, RC | 1 |
| Bhatt, S; Devadoss, T; Jindal, A; Mahesh, R | 1 |
| John, P; McConnell, K; Saif, MW | 1 |
| Bani, M; Deus, J; Farré, M; Fernandes, S; Fina, P; Giménez, M; López-Solà, M; Martín-Santos, R; Merlo-Pich, E; Ortiz, H; Pujol, J; Soriano-Mas, C; Zancan, S | 1 |
| Auinger, P; Christine, CW; Factor, SA; Juncos, J; Leentjens, AF; Lyness, JM; Marsh, L; McDonald, W; Moonen, AJ; Panisset, M; Pfeiffer, R; Richard, IH; Rottenberg, D; Serrano Ramos, C; Shulman, L; Singer, C; Slevin, J; Wijers, A | 1 |
| Baltes, BB; Grekin, ER; Kirsch, I; Loree, AM; Sugarman, MA | 1 |
| Cook, A; Forster, GL; Mears, M; Renner, KJ; Scholl, JL; Tu, W; Watt, MJ | 1 |
| Bennis, M; Bentefour, Y; Garcia, R; M'hamed, SB | 1 |
| Akindipe, TO; Ipser, JC; Sager, C; Stein, DJ; Wilson, D | 1 |
| Blanco, C; Cohen, JN; Drabick, DA; Heimberg, RG; Liebowitz, MR; Potter, CM; Schneier, FR | 1 |
| Amodeo, LR; Crawford, CA; Eaton, SE; Greenfield, VY; Harmony, ZR; Humphrey, DE; Johnson, JD; Pipkin, JA; Plant, CP; Varela, V; Wang, L | 1 |
| Argyropoulos, SV; Bell, CJ; Hood, SD; Nutt, DJ | 1 |
| Chen, DY; Gu, X; Jia, L; Jiang, SM; Xie, HL; Xu, J | 1 |
| Amsterdam, JD; DeRubeis, RJ; Hollon, SD; Schalet, BD; Shelton, RC; Tang, TZ | 1 |
| Bespalov, AY; Gross, G; Mezler, M; Schoemaker, H; Sukhotina, IA; van Gaalen, MM; Wicke, K | 1 |
| Bienfait, K; Buyske, S; Dicke, A; Dobkin, RD; Gara, M; Marin, H; Mark, MH; Menza, M | 1 |
| David, DJ; Deltheil, T; Gardier, AM; Hen, R; Reperant, C; Tanaka, K | 1 |
| Boulenger, JP; Hermes, A; Huusom, AK; Weiller, E | 1 |
| Nibuya, M; Nomura, S; Takahashi, T | 1 |
| Aprile, S; Cabrino, C; De Panfilis, C; Marchesi, C; Parenti, P | 1 |
| Spinhoven, P; Van der Does, AJ; Van Dijk, E; Van Rood, YR | 1 |
| Audi, EA; Biesdorf de Almeida, C; de Mello, JC; Klein, T; Roncon, CM | 1 |
| Akulova, VK; Fedotova, IuO; Ordian, NÉ; Pivina, SG | 1 |
| David, DJ; Deltheil, T; Gardier, AM; Guiard, BP; Guilloux, JP; Hen, R; Nguyen, HT; Rainer, Q; Repérant, C; Toth, M; Xia, L | 1 |
| Akulova, VK; Fedotova, YO; Ordian, NÉ; Pivina, SG | 1 |
| Hetzenauer, A; Sartori, SB; Singewald, N; Whittle, N | 1 |
| Campbell Burton, CA; Gillespie, D; Holmes, J; Knapp, P; Lightbody, CE; Murray, J; Watkins, CL | 1 |
| Hirano, J; Kuwahara, T; Nomura, S; Ogawa, T; Suda, T; Takahashi, T; Teraishi, T | 1 |
| Gross, M; Lisson, S; Nesher, E; Pinhasov, A; Tikhonov, T; Yadid, G | 1 |
| Andrade, C | 1 |
| Bhatt, S; Devadoss, T; Jindal, A; Kumar, B; Mahesh, R; Pandey, DK | 1 |
| Claxton, A; Hackett, ML; Hankey, GJ; Hsieh, CF; Kutlubaev, MA; Lee, R; Mead, GE | 1 |
| Baumann, P; Bovier, P; Eap, CB; Giannakopoulos, P; Giroud, C; Hilleret, H; Rivier, L; Voirol, P; Zullino, D | 1 |
| Finfgeld, DL | 1 |
| Davenport, E; Velamoor, R | 1 |
| Bailey, J; Bell, C; Nutt, D; Rich, A; Wilson, S | 1 |
| Chaudhry, HR; Qureshi, Z; Tareen, IA; Yazdani, I | 1 |
| Landgraf, R | 1 |
| Akiyoshi, J; Fujiki, M; Horinouchi, Y; Isogawa, K; Kodama, K; Nagayama, H; Tsutsumi, T | 1 |
| Andreatini, R; Beijamini, V | 2 |
| Murakami, N; Nagai, T; Narita, N; Sakuta, R; Tazoe, M | 1 |
| Keller, MB | 1 |
| Capuron, L; Fuchs, D; Lawson, DH; Miller, AH; Musselman, DL; Nemeroff, CB; Neurauter, G | 1 |
| Flechter, S; Klein, C; Kushnir, M; Pollak, L; Stryjer, R; Teitler, J | 1 |
| Cole, JC; Marsden, CA; O'Shea, E; Sumnall, HR | 1 |
| Dursun, SM; Haddad, PM | 1 |
| Brooks, SJ; Kutcher, S | 1 |
| Malik, AR; Ravasia, S; Wolf, PK | 1 |
| Holsboer, F; Keck, ME; Landgraf, R; Müller, MB; Ohl, F; Sartori, SB; Singewald, N; Welt, T | 1 |
| Bourin, M; Hascoët, M; Nic Dhonnchadha, BA; Ripoll, N; Sébille, V | 1 |
| Bourin, M; Hascoët, M; Massé, F | 1 |
| Kurlan, R | 1 |
| Boerngen-Lacerda, R; Goeldner, FO; Machado, HB; Pigatto, G; Ribeiro, AF | 1 |
| Berensen, NM; Bloch, M; Braun, A; Calis, K; Grothe, D; Smith, PJ; Stager, SV | 1 |
| Bhanji, NH; Chouinard, G; Kolivakis, T; Margolese, HC | 1 |
| Ando, RD; Bagdy, G; Benko, A; Ferrington, L; Kelly, PA; Kirilly, E | 1 |
| Jaber, BL; Lobon, LF; Madias, NE | 1 |
| Hogg, S; Jessa, M; Michan, L | 1 |
| Bruce, KR; Israel, M; Ng Ying Kin, NM; Steiger, H | 1 |
| Baxter, LR; Brody, AL; Maidment, KM; Saxena, S | 1 |
| Corace, E; De Fazio, P; De Fazio, S; De Sarro, G; Gallelli, L; Garcia, CS | 1 |
| Hoelzl, U; Landgraf, R; Muigg, P; Neumann, I; Palfrader, K; Singewald, N; Wigger, A | 1 |
| Arbuzov, AL; Khurbatova, IG; Reznik, AM | 1 |
| Bar-Oz, B; Bérard, A; Boskovic, R; Einarson, A; Einarson, T; Koren, G; Malm, H; O'Brien, L | 1 |
| Cantoni, A; De Panfilis, C; Giannelli, MR; Maggini, C; Marchesi, C | 1 |
| Aisa, B; Del Rio, J; Elizalde, N; Gil-Bea, FJ; Lasheras, B; Ramírez, MJ; Tordera, RM | 1 |
| Arora, RC; Crayton, JW; Fichtner, CG; O'Connor, FL; Yeoh, HC | 1 |
| Meier, E; Sánchez, C | 1 |
| Hengeveld, MW; Waldinger, MD; Zwinderman, AH | 1 |
| Andersch, B; Eriksson, E; Sundblad, C; Wikander, I | 1 |
| Arana, GW; Grimes, JB; Labbate, LA | 1 |
| Bakish, D; Beauclair, L; Bélanger, MC; Chouinard, G; Manchanda, R; Morris, P; O'Neill, MC; Ravindran, A; Reesal, R; Remick, R; Saxena, B; Vasavan Nair, NP | 1 |
| Christensen, HD; Coleman, FH; Gonzalez, CL; Rayburn, WF | 1 |
| Hartman, EE; Parker, RA | 1 |
| Crawford, J; Ellis, MJ; Hanfelt, JJ; Hayes, DF; Isaacs, C; Kramer, R; Lawrence, W; Rowland, J; Stearns, V | 1 |
| Fava, M; Hoog, SL; Kopp, JB; Nilsson, ME; Rosenbaum, JF; Tepner, RG | 1 |
| Duxon, MS; Starr, KR; Upton, N | 1 |
| Arancio, C; Bellodi, L; Bertani, A; Caldirola, D; Perna, G | 1 |
| Abramov, U; Beljajev, S; Bourin, M; Kõks, S; Koovit, I; Vasar, E | 1 |
| Perry, CM; Wellington, K | 1 |
| Berthoz, A; Chapouthier, G; Jouvent, R; Lepicard, EM; Rudrauf, D; Venault, P | 1 |
| Li, C; Liu, M; Wu, W | 1 |
| Huot, RL; Meaney, MJ; Plotsky, PM; Thrivikraman, KV | 1 |
| Arbuzov, AL; Litvintsev, SV; Mironychev, GN; Reznik, AM | 1 |
| Dunbar, GC; Fuell, DL; Sheehan, D | 1 |
| Dunbar, GC; Fuell, DL | 1 |
| Montgomery, SA | 1 |
| Briley, M; Chopin, P; Moret, C | 1 |
14 review(s) available for paroxetine and Anxiety
| Article | Year |
|---|---|
Sertraline-Induced Tics: A Case Report and Narrative Review.
Topics: Adolescent; Adult; Anxiety; Female; Humans; Observational Studies as Topic; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Tics | 2023 |
Antidepressant discontinuation syndrome: A state-of-the-art clinical review.
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 2023 |
Interventions for treating anxiety after stroke.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Buspirone; Depression; Humans; Middle Aged; Paroxetine; Pilot Projects; Psychotherapy; Randomized Controlled Trials as Topic; Relaxation Therapy; Stroke | 2017 |
Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression.
Topics: Adult; Akathisia, Drug-Induced; Anxiety; Citalopram; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Paroxetine; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2017 |
What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence.
Topics: Adult; Anxiety; Citalopram; Depression; Female; Humans; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Serotonin | 2017 |
The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Anxiety Disorders; Clinical Trials as Topic; Depression; Double-Blind Method; Humans; Panic Disorder; Paroxetine; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2014 |
Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Topics: Alcohol-Related Disorders; Anxiety; Anxiety Disorders; Buspirone; Comorbidity; Desipramine; Humans; Paroxetine; Phobia, Social; Publication Bias; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2015 |
Don't panic. A guide to tryptophan depletion with disorder-specific anxiety provocation.
Topics: Anxiety; Anxiety Disorders; Humans; Male; Paroxetine; Serotonin; Tryptophan | 2016 |
Interventions for treating anxiety after stroke.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Buspirone; Humans; Paroxetine; Psychotherapy; Randomized Controlled Trials as Topic; Stroke | 2011 |
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
Topics: Adult; Anxiety; Citalopram; Cognition; Depression; Fluoxetine; Humans; Nervous System Diseases; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stroke; Stroke Rehabilitation | 2012 |
Paroxetine treatment of major depressive disorder.
Topics: Acute Disease; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder, Major; Humans; Long-Term Care; Paroxetine; Treatment Outcome | 2003 |
Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena.
Topics: Aged; Akathisia, Drug-Induced; Anxiety; Female; Humans; Panic Disorder; Paroxetine; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome | 2006 |
Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
Topics: Abnormalities, Drug-Induced; Adult; Amniocentesis; Antidepressive Agents, Second-Generation; Anxiety; Depression; Electrocardiography; Female; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimesters; Ultrasonography | 2007 |
Venlafaxine extended-release: a review of its use in the management of major depression.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Interactions; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
32 trial(s) available for paroxetine and Anxiety
| Article | Year |
|---|---|
Efficacy and Safety of Jianpi Jieyu Decoction for Patients with Mild-to-Moderate Depression of Xin (Heart)-Pi (Spleen) Deficiency Syndrome: A Multi-centre Randomized Controlled Study.
Topics: Anxiety; Double-Blind Method; Humans; Medicine, Chinese Traditional; Paroxetine; Spleen; Syndrome; Treatment Outcome | 2023 |
Predictors and trajectories of treatment response to SSRIs in patients suffering from PTSD.
Topics: Anxiety; Anxiety Disorders; Child; Double-Blind Method; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic | 2021 |
Effects of anxiety on suicidal ideation: exploratory analysis of a paroxetine versus bupropion randomized trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Suicidal Ideation; Suicide, Attempted; Treatment Outcome | 2018 |
Affect, interpersonal behaviour and interpersonal perception during open-label, uncontrolled paroxetine treatment of people with social anxiety disorder: a pilot study
Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Anxiety; Depression; Female; Humans; Interpersonal Relations; Male; Middle Aged; Paroxetine; Phobia, Social; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Social Behavior; Social Perception; Young Adult | 2018 |
Promoting the well-being of mothers with multidisciplinary psychosocial interventions in the perinatal period.
Topics: Adult; Antidepressive Agents; Anxiety; Combined Modality Therapy; Depression; Depression, Postpartum; Female; Humans; Longitudinal Studies; Mothers; Paroxetine; Patient Acceptance of Health Care; Perinatal Care; Pregnancy; Pregnancy Complications; Psychotherapy; Risk Factors; Sertraline; Treatment Outcome | 2019 |
Dynamics and persistence of CYP2D6 inhibition by paroxetine.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Depression; Dextromethorphan; Dextrorphan; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Young Adult | 2013 |
Treating individuals with social anxiety disorder and at-risk drinking: phasing in a brief alcohol intervention following paroxetine.
Topics: Adaptation, Psychological; Adult; Alcohol Drinking; Antidepressive Agents, Second-Generation; Anxiety; Anxiety Disorders; Combined Modality Therapy; Diagnosis, Dual (Psychiatry); Female; Humans; Male; Paroxetine; Phobic Disorders; Social Behavior Disorders | 2013 |
Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
Topics: Adolescent; Anxiety; Attention Deficit and Disruptive Behavior Disorders; Behavioral Symptoms; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Fluoxetine; Humans; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy.
Topics: Affect; Antidepressive Agents; Anxiety; Cognition; Cognitive Behavioral Therapy; Depression; Humans; Paroxetine; Suicidal Ideation; Symptom Assessment | 2013 |
Functional effects of chronic paroxetine versus placebo on the fear, stress and anxiety brain circuit in Social Anxiety Disorder: initial validation of an imaging protocol for drug discovery.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety; Brain; Brain Mapping; Fear; Female; Humans; Image Processing, Computer-Assisted; Male; Motor Activity; Paroxetine; Phobic Disorders; Speech; Stress, Psychological; Time Factors; Visual Analog Scale; Visual Perception; Young Adult | 2014 |
Comparison of paroxetine and amitriptyline in the treatment of refractory globus pharyngeus.
Topics: Adult; Amitriptyline; Antidepressive Agents; Anxiety; China; Depression; Double-Blind Method; Female; Humans; Lansoprazole; Male; Middle Aged; Paroxetine; Pharyngeal Diseases; Prospective Studies; Proton Pump Inhibitors; Psychiatric Status Rating Scales; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2016 |
Specific Pharmacological Effects of Paroxetine Comprise Psychological but Not Somatic Symptoms of Depression.
Topics: Anxiety; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Medically Unexplained Symptoms; Norepinephrine; Paroxetine; Personality; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Treatment Outcome | 2016 |
A controlled trial of antidepressants in patients with Parkinson disease and depression.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety; Cognition; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Parkinson Disease; Paroxetine; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sleep; Social Behavior; Treatment Outcome | 2009 |
Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Citalopram; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Time Factors | 2010 |
Heart-focused anxiety as a mediating variable in the treatment of noncardiac chest pain by cognitive-behavioral therapy and paroxetine.
Topics: Adult; Aged; Analysis of Variance; Anxiety; Anxiety Disorders; Chest Pain; Cognitive Behavioral Therapy; Double-Blind Method; Fear; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Pain Measurement; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2010 |
Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers.
Topics: Adult; Affect; Anxiety; Blood Pressure; Cross-Over Studies; Drug Therapy, Combination; Eye Movements; Humans; Male; Paroxetine; Pindolol; Pulse; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Sleep; Sleep, REM | 2003 |
Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2002 |
Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Depression; Double-Blind Method; Female; Humans; Interferon-alpha; Kynurenine; Male; Melanoma; Middle Aged; Neopterin; Paroxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; Tryptophan | 2003 |
The Kutcher Generalized Social Anxiety Disorder Scale for Adolescents: assessment of its evaluative properties over the course of a 16-week pediatric psychopharmacotherapy trial.
Topics: Adolescent; Aging; Antidepressive Agents, Second-Generation; Anxiety; Child; Depressive Disorder; Double-Blind Method; Female; Humans; Interpersonal Relations; Male; Paroxetine; Phobic Disorders; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Sex Characteristics; Treatment Outcome | 2004 |
Treatment with medications affecting dopaminergic and serotonergic mechanisms: effects on fluency and anxiety in persons who stutter.
Topics: Adult; Anxiety; Cross-Over Studies; Dopamine Antagonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Pimozide; Selective Serotonin Reuptake Inhibitors; Stuttering; Substance Withdrawal Syndrome; Treatment Outcome; Verbal Behavior | 2005 |
Paroxetine treatment of compulsive hoarding.
Topics: Adult; Anxiety; Compulsive Behavior; Depression; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires | 2007 |
[Clinical picture and treatment of panic disorder accompanied with generalized anxiety].
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety; Combined Modality Therapy; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Psychotherapy; Treatment Outcome | 2007 |
Effect of pharmacological treatment on temperament and character in panic disorder.
Topics: Adult; Anxiety; Character; Citalopram; Female; Follow-Up Studies; GABA Modulators; Humans; Lorazepam; Male; Panic Disorder; Paroxetine; Personality Disorders; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Temperament | 2008 |
Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Anxiety; Dose-Response Relationship, Drug; Double-Blind Method; Ejaculation; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 1997 |
A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side-effects during ten cycles of treatment.
Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Anxiety; Appetite; Body Water; Female; Humans; Paroxetine; Premenstrual Syndrome; Psychiatric Status Rating Scales | 1997 |
Serotonin reuptake antidepressant effects on sexual function in patients with anxiety disorders.
Topics: 1-Naphthylamine; Adult; Anxiety; Ejaculation; Female; Fluoxetine; Humans; Libido; Male; Middle Aged; Orgasm; Paroxetine; Penile Erection; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological | 1998 |
A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder.
Topics: Adult; Anxiety; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 1999 |
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.
Topics: Adult; Aged; Anxiety; Breast Neoplasms; Confidence Intervals; Depression; Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Pilot Projects; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Surveys and Questionnaires; Survivors | 2000 |
Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Carbon Dioxide; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Multivariate Analysis; Panic Disorder; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
The effect of paroxetine on anxiety and agitation associated with depression.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Anxiety; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Psychiatric Status Rating Scales | 1992 |
The anti-anxiety and anti-agitation effects of paroxetine in depressed patients.
Topics: Anxiety; Databases, Factual; Depressive Disorder; Female; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Psychomotor Agitation | 1992 |
71 other study(ies) available for paroxetine and Anxiety
| Article | Year |
|---|---|
Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice.
Topics: Animals; Anxiety; Citalopram; Male; Mice; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2022 |
A novel stress re-stress model: modification of re-stressor cue induces long-lasting post-traumatic stress disorder-like symptoms in rats.
Topics: Animals; Anxiety; Behavior, Animal; Cognitive Dysfunction; Corticosterone; Cues; Depression; Disease Models, Animal; Electric Stimulation; Hypothalamo-Hypophyseal System; Male; Paroxetine; Rats; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic | 2020 |
Antidepressant treatment strategy with an early onset of action improves the clinical outcome in patients with major depressive disorder and high anxiety: a multicenter and 6-week follow-up study.
Topics: Antidepressive Agents; Anxiety; Citalopram; Depressive Disorder, Major; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Least-Squares Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2020 |
BiteStrip analysis of the effect of fluoxetine and paroxetine on sleep bruxism.
Topics: Adult; Anxiety; Dental Devices, Home Care; Depression; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Bruxism; Treatment Outcome | 2017 |
Early adolescent stress-induced changes in prefrontal cortex miRNA-135a and hippocampal miRNA-16 in male rats.
Topics: Age Factors; Animals; Anxiety; Disease Models, Animal; Hippocampus; Male; MicroRNAs; Paroxetine; Prefrontal Cortex; Pyrimidines; Pyrroles; Rats; Receptor, Serotonin, 5-HT1A; Receptors, Corticotropin-Releasing Hormone; Selective Serotonin Reuptake Inhibitors; Spatial Memory; Stress, Psychological | 2017 |
The Rodent-versus-wild Snake Paradigm as a Model for Studying Anxiety- and Panic-like Behaviors: Face, Construct and Predictive Validities.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety; Dose-Response Relationship, Drug; Elapidae; Escape Reaction; Limbic System; Male; Mesocricetus; Models, Animal; Panic; Panic Disorder; Paroxetine; Predatory Behavior; Proto-Oncogene Proteins c-fos | 2018 |
[Exploring the clinical characters of Shugan Jieyu capsule through text mining].
Topics: Anxiety; Data Mining; Depression; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Fluoxetine; Humans; Paroxetine; Sertraline | 2017 |
Effectiveness of paroxetine in the treatment of poststroke depression.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Anxiety; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Retrospective Studies; Stroke; Treatment Outcome | 2018 |
Observational multicenter study of efficacy of paroxetine filmcoated tablet in the treatment of anxiety disorder.
Topics: Adult; Anxiety; Anxiety Disorders; Cohort Studies; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tablets; Treatment Outcome | 2018 |
Alleviating Effect of Antidepressant Treatment on Psychiatric Symptoms and Cardiac Conditions in a Patient with Coronary Slow Flow Comorbid with Depression and Anxiety.
Topics: Antidepressive Agents; Anxiety; Comorbidity; Depression; Female; Humans; Middle Aged; Myocardial Infarction; Paroxetine | 2018 |
Increased 5-HT2C receptor editing predisposes to PTSD-like behaviors and alters BDNF and cytokines signaling.
Topics: Amygdala; Animals; Anxiety; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cytokines; Disease Models, Animal; Fear; Hippocampus; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Paroxetine; Receptor, Serotonin, 5-HT2C; RNA Editing; RNA, Messenger; Signal Transduction; Stress Disorders, Post-Traumatic | 2019 |
A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy.
Topics: Anxiety; Depressive Disorder, Major; Female; Fluoxetine; Humans; Hydroxyzine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Syndrome; Young Adult | 2020 |
Anti-depressant like activity of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (6o) a 5-HT3 receptor antagonist.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Depression; Fluoxetine; Guinea Pigs; Mice; Motor Activity; Olfactory Bulb; Paroxetine; Quinoxalines; Rats; Rats, Wistar; Serotonin 5-HT3 Receptor Antagonists; Swimming | 2013 |
Chin tremors associated with paroxetine in a patient with pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Anxiety; Chemotherapy, Adjuvant; Chin; Deoxycytidine; Female; Gemcitabine; Humans; Pancreatic Neoplasms; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tremor; Withholding Treatment | 2013 |
Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
Topics: Aged; Antidepressive Agents; Anxiety; Cyclohexanols; Datasets as Topic; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Paroxetine; Predictive Value of Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Severity of Illness Index; Venlafaxine Hydrochloride | 2014 |
Serotonin in the ventral hippocampus modulates anxiety-like behavior during amphetamine withdrawal.
Topics: 5,7-Dihydroxytryptamine; Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Central Nervous System Stimulants; Disease Models, Animal; Hippocampus; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Substance Withdrawal Syndrome | 2014 |
Effects of paroxetine on PTSD-like symptoms in mice.
Topics: Animals; Anxiety; Avoidance Learning; Electroshock; Fear; Male; Mice; Paroxetine; Stress Disorders, Post-Traumatic; Treatment Outcome | 2015 |
Clinical presentation and pharmacotherapy response in social anxiety disorder: The effect of etiological beliefs.
Topics: Adolescent; Adult; Anxiety; Depression; Emotions; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Paroxetine; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2015 |
Effects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent rats.
Topics: Age Factors; Animals; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Male; Maze Learning; Mood Disorders; Paroxetine; Rats; Rats, Sprague-Dawley; Sensory Gating; Treatment Outcome | 2015 |
Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression.
Topics: Amino Acids; Amphetamine; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Operant; Darkness; Depression; Diazepam; Fever; Fluoxetine; Light; Male; Mice; Paroxetine; Receptors, Metabotropic Glutamate; Reinforcement Schedule; Stress, Psychological; Xanthenes | 2008 |
Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Brain-Derived Neurotrophic Factor; Citalopram; Depression; Disease Models, Animal; Drug Synergism; Hippocampus; In Situ Hybridization; Male; Mice; Microdialysis; Microinjections; Motor Activity; Paroxetine; Receptor, trkB; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors | 2009 |
Delusion of Cotard's syndrome successfully treated with a dopamine agonist.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Benzothiazoles; Delusions; Depressive Disorder, Major; Dopamine Agonists; Female; Follow-Up Studies; Humans; Middle Aged; Paroxetine; Pramipexole; Recurrence; Syndrome; Treatment Outcome | 2010 |
Defense style in panic disorder before and after pharmacological treatment.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety; Checklist; Citalopram; Defense Mechanisms; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Surveys and Questionnaires | 2011 |
Anxiolytic effects of a semipurified constituent of guaraná seeds on rats in the elevated T-maze test.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Disease Models, Animal; Dopamine Agents; Escape Reaction; Locomotion; Male; Maze Learning; Metergoline; Panic; Paroxetine; Paullinia; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Seeds; Serotonin Agents; Sulpiride | 2011 |
[Comparative efficacy of selective serotonin reuptake inhibitors in young prenatally stressed female rats].
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Female; Fluoxetine; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sexual Maturation; Stress, Psychological | 2010 |
Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Body Temperature Regulation; Disease Models, Animal; Frontal Lobe; Gene Expression; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Paroxetine; Raphe Nuclei; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Synaptic Transmission | 2011 |
[Influence of fluoxetine and paroxetine on anxiety-like behavior in young and adult prenatally stressed male rats].
Topics: Age Factors; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Behavior, Animal; Female; Fluoxetine; Male; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sex Factors; Stress, Psychological | 2011 |
Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment.
Topics: Adrenocorticotropic Hormone; Analysis of Variance; Animals; Anxiety; Corticosterone; Corticotropin-Releasing Hormone; Dark Adaptation; Desipramine; Disease Models, Animal; Exploratory Behavior; Fever; Food Deprivation; Hypothalamo-Hypophyseal System; Magnesium; Magnesium Deficiency; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Paroxetine; Pituitary-Adrenal System; Protein Precursors; Proto-Oncogene Proteins c-fos; Radioimmunoassay; Reaction Time; RNA, Messenger; Stress, Psychological | 2012 |
Successful treatment of olfactory reference syndrome with paroxetine.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Female; Humans; Middle Aged; Odorants; Paroxetine; Somatoform Disorders | 2012 |
Differential responses to distinct psychotropic agents of selectively bred dominant and submissive animals.
Topics: Aggression; Analysis of Variance; Animals; Antimanic Agents; Anxiety; Behavior, Animal; Diazepam; Dominance-Subordination; Drinking; Hypnotics and Sedatives; Lithium Chloride; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Motor Activity; Paroxetine; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Swimming | 2013 |
Breast cancer and antidepressant use.
Topics: Adult; Aged; Antidepressive Agents; Anxiety; Breast Neoplasms; Contraindications; Cytochrome P-450 CYP2D6 Inhibitors; Depression; Drug Interactions; Female; Hot Flashes; Humans; Paroxetine; Prodrugs; Selective Estrogen Receptor Modulators; Survival Analysis; Tamoxifen | 2012 |
Antidepressant and anxiolytic-like effects of 4n, a novel 5-HT3 receptor antagonist using behaviour based rodent models.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Depression; Emotions; Mice; Olfactory Bulb; Ondansetron; Paroxetine; Photoperiod; Quinoxalines; Rats; Rats, Wistar; Reserpine; Serotonin 5-HT3 Receptor Antagonists; Swimming | 2012 |
Very long half-life of paroxetine following intoxication in an extensive cytochrome P4502D6 metabolizer.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Clorazepate Dipotassium; Cytochrome P-450 CYP2D6; Depressive Disorder; Drug Interactions; Drug Overdose; Female; Half-Life; Humans; Middle Aged; Paroxetine; Suicide, Attempted | 2002 |
Selective serotonin reuptake inhibitor. Discontinuation syndrome.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Dizziness; Drug Administration Schedule; Humans; Male; Nurse Practitioners; Paroxetine; Patient Education as Topic; Psychiatric Nursing; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Treatment Refusal | 2002 |
A case of paroxetine-induced galactorrhea.
Topics: Adult; Antipsychotic Agents; Anxiety; Depression; Female; Galactorrhea; Humans; Paroxetine | 2002 |
[Neurobiology and genetics of anxiety in an animal model].
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Arginine Vasopressin; Arousal; Corticotropin-Releasing Hormone; Depression; Dexamethasone; Disease Models, Animal; Hypothalamo-Hypophyseal System; Motor Activity; Paroxetine; Phenotype; Pituitary-Adrenal System; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Rats; Rats, Inbred Strains; Receptors, Vasopressin | 2003 |
Anxiety induced by repetitive transcranial magnetic stimulation is suppressed by chronic treatment of paroxetine in rats.
Topics: Acute Disease; Animals; Anxiety; Chronic Disease; Electric Stimulation; Fear; Male; Maze Learning; Motor Activity; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Transcranial Magnetic Stimulation | 2003 |
Effects of Hypericum perforatum and paroxetine in the mouse defense test battery.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Avoidance Learning; Escape Reaction; Hypericum; Male; Mice; Paroxetine; Plant Extracts | 2003 |
Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze.
Topics: Analysis of Variance; Animals; Anxiety; Avoidance Learning; Drug Administration Schedule; Hypericum; Male; Maze Learning; Panic; Panic Disorder; Paroxetine; Plant Extracts; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Swimming | 2003 |
[Anxiety in school refusal children with indefinite complaints: psychological estimation using State-Trait Anxiety Inventory and therapy by serotonin reuptake inhibitors].
Topics: Adolescent; Anxiety; Child; Female; Fluvoxamine; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Student Dropouts; Treatment Outcome | 2003 |
Paroxetine: new indication. In generalised anxiety: uncertain efficacy.
Topics: Anxiety; Clinical Trials as Topic; Drug Approval; France; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2003 |
Which SSRI?
Topics: Adolescent; Anxiety; Child; Depressive Disorder; Drug Interactions; Fluoxetine; Half-Life; Humans; Monoamine Oxidase Inhibitors; Paroxetine; Selective Serotonin Reuptake Inhibitors; Suicide Prevention | 2003 |
Phobic postural vertigo: a new proposed entity.
Topics: Adolescent; Adult; Aged; Anxiety; Female; Humans; Male; Middle Aged; Panic; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Vertigo | 2003 |
The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test.
Topics: Animals; Anxiety; Drug Interactions; Hippocampus; Illicit Drugs; Male; Maze Learning; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Protein Binding; Rats | 2004 |
Re: Depression, stroke diagnosis, and SSRI discontinuation syndrome.
Topics: Aged; Anxiety; Ataxia; Dementia, Multi-Infarct; Humans; Magnetic Resonance Imaging; Male; Paroxetine; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 2004 |
Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety.
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Bupropion; Citalopram; Cyclohexanols; Depression; Drug Therapy; Fluoxetine; Humans; Paroxetine; Patient Satisfaction; Primary Health Care; Psychiatry; Psychology; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Work | 2004 |
Recurrent paroxetine-induced hyponatremia.
Topics: Aged; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Paroxetine; Recurrence; Sodium Chloride | 2004 |
Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Anxiety; Autoradiography; Behavior, Animal; Binding Sites; Chromatography, High Pressure Liquid; Dexamethasone; Disease Models, Animal; Hippocampus; In Situ Hybridization; Male; Maze Learning; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Paroxetine; Rats; Serotonin; Serotonin Plasma Membrane Transport Proteins; Stress, Psychological | 2005 |
The four-plates test-retest paradigm to discriminate anxiolytic effects.
Topics: Adrenergic Uptake Inhibitors; Amphetamines; Animals; Anti-Anxiety Agents; Anxiety; Atropine; Avoidance Learning; Behavior, Animal; Benzodiazepines; Cholinergic Agents; Cyclohexanols; Discrimination, Psychological; Dose-Response Relationship, Drug; Male; Mice; Paroxetine; Receptors, GABA-A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Venlafaxine Hydrochloride | 2005 |
alpha2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Citalopram; Clonidine; Cyclohexanols; Cyclopropanes; Dose-Response Relationship, Drug; Drug Antagonism; Guanabenz; Male; Mice; Milnacipran; Motor Activity; Paroxetine; Punishment; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric; Venlafaxine Hydrochloride | 2005 |
"Fear of falling" gait: a potentially reversible psychogenic gait disorder.
Topics: Aged; Anxiety; Diagnosis, Differential; Fear; Female; Gait Disorders, Neurologic; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2005 |
Influence of fluoxetine and paroxetine in behavioral sensitization induced by ethanol in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Behavior, Animal; Central Nervous System Depressants; Ethanol; Exploratory Behavior; Fear; Fluoxetine; Male; Mice; Motor Activity; Paroxetine | 2005 |
Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test.
Topics: Animals; Anxiety; Behavior, Animal; Brain; Male; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Rats; Serotonin Agents; Social Behavior | 2006 |
The serotonin syndrome complicating co-prescription of paroxetine and clarithromycin.
Topics: Adult; Anti-Bacterial Agents; Antidepressive Agents, Second-Generation; Anxiety; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Drug Prescriptions; Enzyme Inhibitors; Female; Humans; Paroxetine; Respiratory Tract Infections; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome | 2006 |
Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety.
Topics: Adrenergic alpha-Antagonists; Alprazolam; Animals; Anxiety; Citalopram; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Hypnotics and Sedatives; Male; Motor Activity; Panic Disorder; Paroxetine; Periaqueductal Gray; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stereotaxic Techniques; Yohimbine | 2006 |
Reduced platelet [3H]paroxetine binding in anorexia nervosa: relationship to eating symptoms and personality pathology.
Topics: Adolescent; Adult; Anorexia Nervosa; Anxiety; Blood Platelets; Body Mass Index; Bulimia; Depression; Diet, Reducing; Feeding Behavior; Female; Humans; Paroxetine; Personality Disorders; Personality Inventory; Psychometrics; Radioligand Assay; Serotonin Plasma Membrane Transport Proteins; Tritium | 2006 |
Generalised urticaria in a young woman treated with clomipramine and after ingestion of codfish.
Topics: Adult; Alprazolam; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Clomipramine; Drug Eruptions; Female; Food-Drug Interactions; Gadus morhua; Humans; Hypnotics and Sedatives; Meat; Obsessive-Compulsive Disorder; Paroxetine; Urticaria | 2006 |
Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Anxiety; Brain; Depression; Immobility Response, Tonic; Male; Paroxetine; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Statistics, Nonparametric; Stress, Psychological | 2007 |
Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Depression; Drinking; Escape Reaction; Exploratory Behavior; Fear; Helplessness, Learned; Injections, Intraperitoneal; Long-Term Care; Male; Mental Recall; Mice; Motivation; Motor Activity; Paroxetine; Pattern Recognition, Visual; Recognition, Psychology; Stress, Psychological; Sucrose; Taste | 2008 |
Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: associated clinical features.
Topics: Adult; Anxiety; Blood Platelets; Combat Disorders; Depressive Disorder; Humans; Male; Middle Aged; Paroxetine; Serotonin; Tritium | 1995 |
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
Topics: 1-Naphthylamine; Aggression; Animals; Anxiety; Binding, Competitive; Citalopram; Depression; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Rats; Rats, Wistar; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sertraline; Vocalization, Animal | 1997 |
Behavioral changes in developing mice after prenatal exposure to paroxetine (Paxil)
Topics: Aggression; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Body Weight; Depression; Exploratory Behavior; Female; Homing Behavior; Litter Size; Male; Maternal Exposure; Mice; Motor Activity; Paroxetine; Play and Playthings; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Selective Serotonin Reuptake Inhibitors; Sleep; Time Factors; Vocalization, Animal | 1999 |
An 87-year-old woman taking a benzodiazepine, 1 year later.
Topics: Aged; Aged, 80 and over; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Depression; Drug Therapy, Combination; Female; Humans; Paroxetine; Risk | 1999 |
Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT(1A) receptor antagonist WAY100635.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Disease Models, Animal; Drug Interactions; Hyperkinesis; Interpersonal Relations; Male; Paroxetine; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists | 2000 |
8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anxiety; Camphanes; Exploratory Behavior; Male; Motor Activity; Paroxetine; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists | 2001 |
Balance control and posture in anxious mice improved by SSRI treatment.
Topics: Animals; Anxiety; Central Nervous System; Dose-Response Relationship, Drug; Female; Fluoxetine; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Paroxetine; Postural Balance; Posture; Selective Serotonin Reuptake Inhibitors; Sex Characteristics; Vestibular Diseases | 2001 |
[Clinical characteristics and psychotropic therapy of depressive and anxious symptoms of patients with somatic diseases].
Topics: Adolescent; Adult; Anxiety; Depression; Female; Hospitals, General; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychophysiologic Disorders; Selective Serotonin Reuptake Inhibitors | 1999 |
Development of adult ethanol preference and anxiety as a consequence of neonatal maternal separation in Long Evans rats and reversal with antidepressant treatment.
Topics: Adrenocorticotropic Hormone; Alcohol Drinking; Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Anxiety; Body Weight; Corticosterone; Female; Male; Maternal Deprivation; Paroxetine; Pituitary-Adrenal System; Rats; Rats, Long-Evans; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2001 |
[Paroxetine (paxil): use in clinical practice].
Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Depression; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2002 |
The advantages of paroxetine in different subgroups of depression.
Topics: Anxiety; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Paroxetine; Psychiatric Status Rating Scales; Sleep; Suicide Prevention | 1992 |
Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat.
Topics: 5,7-Dihydroxytryptamine; Animals; Anxiety; Behavior, Animal; Brain Chemistry; Injections, Intraventricular; Kinetics; Male; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin | 1990 |